*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Capecitabine is an oral prodrug of 5-fluorouracil, synthesized via enzymatic conversion for targeted chemotherapy. <strong>Molecular Formula</strong>: C15H22FN3O6; <strong>CAS No.</strong>: 154361-50-9.</p>
<h3>Application</h3>
<ul>
<li>Oncology: First-line treatment for metastatic breast cancer and colorectal carcinoma.</li>
<li>Gastrointestinal Oncology: Adjuvant therapy for stage III colon cancer post-surgery.</li>
<li>Pharmaceutical Manufacturing: API production for oncology drug formulations.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with severe dihydropyrimidine dehydrogenase deficiency. Requires strict temperature control (20-25°C) and moisture protection during storage to maintain stability.</p>